Nuwellis, Inc. announced a private placement with an institutional investor for the purchase of 994,537 shares at $3.09 each, totaling $5.0 million. Additionally, the company entered into a warrant inducement agreement for the exercise of existing warrants at a reduced price of $3.09, resulting in the issuance of 1,247,170 new warrants. The transactions are expected to close on January 30, 2026. Nuwellis focuses on advancing precision fluid management technologies in critical care settings, offering solutions for patient monitoring, therapy, and clinical decision-making. The Aquadex SmartFlow system provides therapy for patients with fluid overload. Nuwellis is headquartered in Minneapolis, Minnesota.

Read more at GlobeNewswire: Nuwellis Announces $5 Million Private Placement and Warrant